Gut–brain and brain–gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet
暂无分享,去创建一个
A. Keshavarzian | A. Kraneveld | J. Garssen | H. Dodiya | L. Broersen | H. Douna | S. Lopes da Silva | P. Perez-Pardo | N. van Wijk | P. Perez‐Pardo
[1] C. Pellegrini,et al. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration , 2016, Journal of Neuroinflammation.
[2] G. O’Keeffe,et al. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. , 2016, Parkinsonism & related disorders.
[3] Valerio Zerbi,et al. A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice , 2016, Neural plasticity.
[4] H. Reichmann,et al. Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors , 2015, Nature Reviews Neurology.
[5] E. Horváth-Puhó,et al. Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.
[6] Elliott W. Dirr,et al. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration , 2015, Neurobiology of Disease.
[7] L. Leclair-Visonneau,et al. Enteric glial cells: New players in Parkinson's disease? , 2015, Movement disorders : official journal of the Movement Disorder Society.
[8] J. Sijben,et al. A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats , 2015, Neurobiology of Aging.
[9] Xuemei Huang,et al. Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis , 2015, Translational Neurodegeneration.
[10] Jia-Yi Li,et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.
[11] E. Youness,et al. Effect of a single intrastriatal rotenone injection on oxidative stress and neurodegeneration in the rat brain , 2014, Comparative Clinical Pathology.
[12] M. Asanuma,et al. Neuroprotective Effects of Metallothionein Against Rotenone-Induced Myenteric Neurodegeneration in Parkinsonian Mice , 2014, Neurotoxicity Research.
[13] L. Niles,et al. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson’s disease , 2014, Neuroscience.
[14] Valerio Zerbi,et al. Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease , 2014, Neurobiology of Aging.
[15] P. Kamphuis,et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.
[16] H. Reichmann,et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice , 2012, Scientific Reports.
[17] T. Dinan,et al. Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .
[18] K. Shannon,et al. Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[19] E. Benarroch,et al. Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers , 2012, Journal of the Neurological Sciences.
[20] Jeffrey H. Kordower,et al. Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease , 2011, PloS one.
[21] Pablo Martinez-Martin,et al. The importance of non-motor disturbances to quality of life in Parkinson's disease , 2011, Journal of the Neurological Sciences.
[22] K. Krogh. Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .
[23] Honglei Chen,et al. Original Contribution A Prospective Study of Bowel Movement Frequency and Risk of Parkinson’s Disease , 2011 .
[24] K. Rea,et al. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone , 2011, Neuroscience.
[25] C. Tanner,et al. Rotenone, Paraquat, and Parkinson’s Disease , 2011, Environmental health perspectives.
[26] R. Wurtman,et al. Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. , 2010, Nutrition reviews.
[27] J. Anselmo-Franci,et al. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease , 2010, Neuroscience Research.
[28] H. Braak,et al. A timeline for Parkinson's disease. , 2010, Parkinsonism & related disorders.
[29] H. Reichmann,et al. Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice , 2010, PloS one.
[30] L. Montero,et al. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology , 2009, Neurobiology of Disease.
[31] S. Srinivasan,et al. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease , 2009, Experimental Neurology.
[32] H. Braak,et al. Parkinson's Disease , 2009, Annals of the New York Academy of Sciences.
[33] H. Berendse,et al. Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study , 2009, Movement disorders : official journal of the Movement Disorder Society.
[34] M. Balda,et al. Tight junctions at a glance , 2008, Journal of Cell Science.
[35] R. Wurtman,et al. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease , 2008, Neuroscience Research.
[36] R. Wurtman,et al. Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats , 2008, Behavioural Brain Research.
[37] F. Cicchetti,et al. Beneficial effects of dietary omega‐3 polyunsaturated fatty acid on toxin‐induced neuronal degeneration in an animal model of Parkinson's disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] M. Maes,et al. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. , 2008, Neuro endocrinology letters.
[39] R. Wurtman,et al. Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus , 2007, Brain Research.
[40] H. Braak,et al. Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.
[41] Pablo Martinez-Martin,et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.
[42] Kazuyuki Takata,et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4‐phenylbutyrate, a chemical chaperone , 2007, Journal of neurochemistry.
[43] W. Koltun,et al. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. , 2007, The Journal of surgical research.
[44] C. Tanner,et al. Association of olfactory dysfunction with incidental Lewy bodies , 2006, Movement disorders : official journal of the Movement Disorder Society.
[45] H. Miwa,et al. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats , 2006, Neuroscience Letters.
[46] M. Cookson,et al. Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system , 2006, Neurobiology of Disease.
[47] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[48] H. Berendse,et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.
[49] G. Wooten,et al. Are men at greater risk for Parkinson’s disease than women? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[50] Todd B. Sherer,et al. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.
[51] C. Tanner,et al. Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.
[52] A. Bylund-Fellenius,et al. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine , 1998, Alimentary pharmacology & therapeutics.
[53] G. C. Wagner,et al. Uridine reduces rotation induced by l-Dopa and methamphetamine in 6-OHDA-treated rats , 1995, Pharmacology Biochemistry and Behavior.
[54] P. G. Reeves,et al. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.
[55] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[56] H. J. G. GUNDERSEN,et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[57] Michaela E Johnson,et al. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. , 2015, Neurotoxicology.
[58] C. Tanner,et al. Dietary fat intake, pesticide use, and Parkinson's disease. , 2014, Parkinsonism & related disorders.
[59] A. Sun,et al. Oxidative and Inflammatory Pathways in Parkinson’s Disease , 2008, Neurochemical Research.
[60] M. Beal,et al. Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity , 2007, NeuroMolecular Medicine.